IMUN

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 1/03/2017
Contact Info
  • 37 North Orange Ave
  • Suite 607
  • Orlando, FL 32801

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001559356
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: FL, USA
Year of Inc. 1998
Employees 6 a/o Dec 11, 2015
Company Officers/Contacts
Noreen Griffin CEO
Peter Aronstam CFO
Dr. Fengping Shan Chief Scientific Officer
Gina Austin General Counsel
Company Directors
Nicholas Plotnikoff Non-Executive Chairman
Paul Akin
Noreen Griffin
Clifford A. Selsky
Edward Teraskiewicz
Service Providers
Accounting/Auditing Firm
Turner, Stone & Company, L.L.P.
12700 Park Central Drive
Suite 1400
Dallas, TX, 75251
United States
 
Securities Counsel
Austin Legal Group
3990 Old Town Ave
Suite A-112
San Diego, CA, 92110
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=TNI BioTech, Inc. until 12-2014
  • Formerly=pH Environmental Inc until 5-2012
  • Formerly=Resort Clubs International, Inc. until 2-2012
  • Formerly=Galliano International Ltd. until 11-04
  • Note=11-10-04 company is in the development stage
IMUN Security Details
Share Structure
Market Value1 $15,670,342 a/o Jun 21, 2017
Authorized Shares 500,000,000 a/o May 31, 2017
Outstanding Shares 313,406,831 a/o May 31, 2017
-Restricted 157,714,258 a/o May 31, 2017
-Unrestricted 155,692,573 a/o May 31, 2017
Held at DTC 129,958,387 a/o May 31, 2017
Float 7,986,000 a/o Dec 11, 2015
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
ClearTrust, LLC
Shareholders
Shareholders of Record 773 a/o Mar 31, 2017
Short Selling Data
Short Interest 96,531 (222.76%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security